Want to track NERV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Minerva Neurosciences Inc. (NERV) Statistics
Valuation metrics
Market Cap 28.11M
Enterprise value 62.06M
Trailing P/E (ttm) -0.15
Forward P/E -10.85
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) -0.74
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.15
Overview
Shares outstanding 43.27M
Float 24.86M
Shares short 1.16M
% Held by insiders 0.04%
% Held by institutions 0.84%
Average volume (10 days) 169.32K
Average volume (90 days) 150.13K
Price summary
52-Week low 1.76
52-Week high 12.46
Beta -0.1
50-Day moving average 4.5
200-Day moving average 5.7
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:8
Last split Date 21 Jun 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -4.41%
Return on equity 3.6%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -5.76M
EBITDA -15.1M
Net income to common (ttm) -293.42M
Diluted EPS (ttm) -9.46
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 82.3M
Total cash per share (mrq) 1.78
Total debt (mrq) 60M
Total Debt/Equity (mrq) -0.26
Current ratio (mrq) 17.65%
Book value per share (mrq) -5.79
Cash Flow
Cash flow statement -13.51M
Levered free cash flow (LFCF) -8.54M
